STAT-Mediated Mitochondrial Regulation in Cardiovascular Diseases: Mechanistic Insights and STAT3-Focused Therapeutic Strategies
Biomolecules · 11.02.2026 · 16 (2) · 286
DOI: 10.3390/biom16020286 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 11.02.2026. Verfasst von Bing Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Hunan University of Chinese Medicine, Changsha 410208, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, STAT3 Transcription Factor, Mitochondria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Graduate Innovation Project at Hunan University of Chinese Medicine, the Hunan Provincial Education Commission Foundation, Hunan Provincial Education Commission Foundation.
Abstract (Originalsprache)
Mitochondria, the cell’s powerhouses, generate ATP to sustain essential biological functions. Dysfunctional mitochondria can lead to cell death and subsequent tissue damage. Mitochondrial impairment is a key driver of cellular dysfunction in cardiomyocytes, endothelial cells, and macrophages, contributing to cardiovascular diseases such as atherosclerosis, myocardial ischemia–reperfusion injury, and cardiac hypertrophy. The signal transducer and activator of transcription (STAT) family regulates immune responses, apoptosis, and cell proliferation. Despite evidence suggesting that STATs influence mitochondrial pathways in various cardiovascular conditions, their roles are often contradictory and context-dependent. This review examines the structural and functional dynamics of STATs, their upstream and downstream signaling networks, and therapeutic strategies targeting STAT3 (the most extensively studied isoform), with a particular focus on natural compounds and pharmacological inhibitors. By synthesizing current findings, this review offers valuable insights into STATs as potential therapeutic targets for mitochondrial dysfunction in cardiovascular diseases, while also highlighting directions for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School, Hunan University of Chinese Medicine, Changsha 410208, China.
- Medical College, Hunan University of Chinese Medicine, Changsha 410208, China.
- School of Public Health, Changsha Medical University, Changsha 410219, China.
- Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha 410219, China.
- College of Traditional Chinese Medicine, Changsha Medical University, Changsha 410219, China.
ORCID-Profile: Bing Guo
Förderung
- Graduate Innovation Project at Hunan University of Chinese Medicine
- the Hunan Provincial Education Commission Foundation
- Hunan Provincial Education Commission Foundation
Zitieren
APA
Guo, B., Fu, Y., Wang, M., Zhu, L., & He, X. (2026). STAT-Mediated Mitochondrial Regulation in Cardiovascular Diseases: Mechanistic Insights and STAT3-Focused Therapeutic Strategies. Biomolecules, 16(2), 286. https://doi.org/10.3390/biom16020286
Vancouver
Guo B, Fu Y, Wang M, Zhu L, He X. STAT-Mediated Mitochondrial Regulation in Cardiovascular Diseases: Mechanistic Insights and STAT3-Focused Therapeutic Strategies. Biomolecules. 2026;16(2):286. doi:10.3390/biom16020286
BibTeX
@article{Guo2026,
author = {Guo, Bing and Fu, Yan and Wang, Min and Zhu, Lemei and He, Xuan},
title = {STAT-Mediated Mitochondrial Regulation in Cardiovascular Diseases: Mechanistic Insights and STAT3-Focused Therapeutic Strategies},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {2},
pages = {286},
doi = {10.3390/biom16020286}
}
EUVIMED